Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 18.30
+0.09 (0.49%)
Jun 24, 2026, 5:30 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 718.19 million as of June 24, 2026. Its market cap has decreased by -24.53% in one year.
Market Cap
718.19M
Enterprise Value
703.62M
Revenue
115.82M
Ranking
n/a
PE Ratio
355.05
Stock Price
18.30
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 718.19M, a decrease of -77.90%. That is a compound annual growth rate of -13.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 718.19M | -33.25% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 254.99B |
| Novartis AG | 216.55B |
| Galderma Group AG | 40.44B |
| Lonza Group AG | 34.83B |
| PolyPeptide Group AG | 1.30B |
| Aevis Victoria | 1.18B |
| Cosmo | 1.11B |
| SKAN Group AG | 1.11B |